2025;14(10):e70947
A 2024 meta-analysis published in the Journal of Endocrine Society examining body composition changes during GLP-1 therapy found that participants engaging in structured resistance training preserved 83% more lean mass compared to those who did no resistance exercise
Blue Cross Blue Shield : Coverage depends on your state and specific plan, with many BCBS plans offering coverage for tirzepatide with the necessary prior authorization and medical necessity documentation
Inspect the semaglutide pen to ensure the medication is clear and colorlessdo not use if the solution appears cloudy, discolored, or contains particles
REFERENCES: Kevin Kargman, Semaglutide and Blood Clots: What You Need to Know for Safety and Health, May 29, 2024 Yaqin Zhang, Ruofei Chen, Yangyang Jia, Mingwei Chen, Zongwen Shuai, Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes, Drug Des Devel Ther 2021 Jul 12;15:30273040 " Ingram, I., GLP-1 Drugs Tied to Reduced Risk of Dangerous Blood Clots, MedPage TodayDecember 8, 2024, ABSTRACT: Patell R "Glucagon-like peptide 1 receptor agonists reduce the risk of venous thromboembolism in patients with diabetes irrespective of obesity: a propensity score-matched multicenter database analysis" ASH 2024